We conducted survival analysis using data from the GEPIA database, and the results indicated that higher SPAG6 expression was correlated with improved disease-free survival in RCC patients (Fig 1G), suggesting a potential tumor-suppressive role for SPAG6. The gene discussed is SPAG6; the disease is neoplasm.